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A B S T R A C T
Objective: To compare the frequency and etiology of diarrhea in children aged less than 2 years with
known HIV status.
Methods: This was a nested cohort study, whereby children were followed during monthly routine and
unscheduled visits. TheHIV status of childrenwas determinedwith PCR. A stool culturewas obtained from
children with diarrhea. A subset of stool samples was examined for parasites and tested for rotavirus.
Results: Between 1997 and 2001, 682 children (51.0%male) contributed observation periods with amean
of47weeks.Overall therewere 198episodesof diarrheaper100child-yearsof observation (CYO);diarrhea
wasmore commonamongHIV-positive children than amongHIV-negative children (321 vs. 183 episodes/
100 CYO, respectively, p < 0.01) and was not statistically different for HIV-negative children born to HIV-
positive compared with HIV-negative mothers (182 vs. 187 episodes/100 CYO, respectively, p = 0.36). For
66.5% of the acute episodes a stool culture was obtained; 27.8% of stool cultures yielded a bacterial
pathogen.Apositive stool culturewas less likelyamongHIV-positive childrencompared to childrenofHIV-
negative mothers (20.5% vs. 34.3%, p = 0.01). Susceptibility of Salmonella and Shigella to commonly used
antibioticswas low. Rotaviruswas detected in 13.9% of 202 examined stool samples, and a stool parasite in
3.8% of 394 samples. Diarrhea was associated with 37.8% of child deaths.
Conclusions: Diarrhea was more common among HIV-infected children, but was not associated with
speciﬁc bacterial pathogens. Measures that reduce diarrhea will beneﬁt all children, but may beneﬁt
HIV-infected children in particular.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Contents lists available at ScienceDirect
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Diarrhea is a major cause of child morbidity and mortality in
developing countries. It is estimated to account for approximately
1.9 million or 18% of deaths among children under 5 years of age
annually, of which approximately 40% occur in the African region.1
Diarrhea is a common cause of morbidity and mortality among
HIV-infected children.2,3 Approximately 2.1million children under* Corresponding author.
E-mail addresses: amvaneijk@yahoo.com, amvaneijk@gmail.com
(A.M. van Eijk).
1201-9712/$36.00 – see front matter . Published by Elsevier Ltd on behalf of Internatio
doi:10.1016/j.ijid.2009.06.00114 years of age are estimated to be infected with HIV worldwide,
and 90.5% of infected children are in sub-Saharan Africa.4 Most
children acquire HIV-infection through vertical transmission from
their mothers, either perinatally or through breastfeeding.
In 1997, we initiated a nested cohort study of diarrheal disease
within a larger prospective cohort study examining the relation-
ship between placental malaria and perinatal mother-to-child
transmission of HIV in an urban/periurban area of western Kenya.5
The purpose of the study was to examine the burden of diarrheal
disease in infants and young children born to HIV-infected and
HIV-uninfected mothers. In the present analysis we examine the
frequency and etiology of diarrhea among HIV-infected and HIV-
uninfected children aged 0–23 months.nal Society for Infectious Diseases.
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2.1. Study site, enrollment, and study population
This study was conducted at an outpatient clinic of the Nyanza
Provincial General Hospital (NPGH) in Kisumu, a city located on the
shores of Lake Victoria in western Kenya with a population of
approximately 300 000. NPGH is a 400-bed government referral
hospital, providing healthcare mostly to the local low-income
population. Study procedures have been described elsewhere.5,6
Pregnant women were screened when visiting the antenatal clinic
of the hospital. At delivery, HIV-seropositive women and their
newborn infants were invited to visit the study clinic for routine
visits every 4 weeks until the child was 2 years of age, and to bring
the child in for sick visits as needed. For comparison, and to avoid
stigmatization of HIV-infected participants, we also enrolled HIV-
seronegative women and their newborns.
From November 1997 to August 2001, we questioned mothers
about diarrhea in their children during routine and unscheduled
visits. Between October 1999 and January 2000 the diarrhea sub-
study was suspended for technical reasons. Enrollment stopped in
August 2000 and follow-up visits ended one year later.
We obtained blood by ﬁnger prick for detection of HIV-DNA by
PCR at the routine visits. Stool sampleswere collected from children
who presented with diarrhea at routine or unscheduled visits.
Caretakers of children forwhomastool culturewasperformed,were
invitedto returnafter1weektoobtain the resultand for follow-upof
the child’s diarrheal illness. Ill children were examined by a clinical
ofﬁcer or the study pediatrician and treated accordingly. At the time
of the study, trimethoprim–sulfamethoxazole prophylaxis was not
yet routinely provided to infants born to HIV-infected women.
Children who did not return for routine follow-up appointments
werevisitedathome.Forchildrenwhowerereportedashavingdied,
we obtained additional information using verbal autopsy. Verbal
autopsy information was reviewed independently by three medical
workers (clinical ofﬁcers or doctors) who each assigned a diagnosis.
If one diagnosiswas given by twoormore reviewers, itwas assigned
as the cause of death. If all three causes were different, a fourth
reviewer was used to adjudicate.
2.2. Laboratory procedures
Stool specimens were obtained either as a whole stool sample
or by rectal swab. Swabs were immediately placed in Cary–Blair
transport medium. Whole stool samples and swabs were kept at
4 8C until same day transport to the Enterics Laboratory run jointly
by the Kenya Medical Research Institute (KEMRI) and the Centers
for Disease Control and Prevention (CDC); all specimens were
processed within 6 hours of collection. Stool specimens were
cultured by standard techniques for Shigella, Salmonella, Campy-
lobacter and Vibrio cholerae; media, reagents, bacterial isolation
techniques, and antimicrobial susceptibility testing were routinely
quality controlled.We determined antimicrobial susceptibilities of
Shigella and Salmonella to ampicillin, amoxicillin–clavulanate,
ceftriaxone, chloramphenicol, ciproﬂoxacin, gentamicin, kanamy-
cin, nalidixic acid, streptomycin, sulﬁsoxazole, tetracycline, and
trimethoprim–sulfamethoxazole by the Kirby–Bauer disk diffusion
method.7 The results of bacterial cultures and antimicrobial
susceptibility testing were returned to the clinician who was
caring for the child within 1 week. We also collected stool for
culture from 96 children without diarrhea in the week before or
after specimen collection to assess the prevalence of potential
pathogens in the absence of diarrheal disease (‘controls’). A subset
of all whole stool samples was tested for parasites and rotavirus.
Detection of intestinal parasites was performed on concentrated
stool samples following the formal–ether concentration method.Wet mounts of stool concentrates were examined by means of
both bright-ﬁeld and ultraviolet ﬂuorescence microscopy. Stool
concentrates were also stained by use of the trichrome technique
and Kinyoun’s modiﬁed acid-fast technique and examined using
bright-ﬁeld microscopy. In addition, stool concentrates were also
tested for Giardia and Cryptosporidium using commercially
available immunoﬂuorescence assay (IFA) test kits. Stool speci-
mens were tested for rotavirus with a commercial antigen
detection kit (Premier Rotaclone, Meriﬂuor, Meridian Bioscience,
Inc., Cincinnati, OH, USA). Each sample was diluted in 1 ml of kit
sample buffer and then tested in an enzyme immunoassay
according to the manufacturer’s instructions. Samples with an
optical density reading of 0.150 at 450 nm were considered
positive for rotavirus.
Women were initially screened for HIV with Serostrip HIV-1/2
(Saliva Diagnostic Systems Pte. Ltd, Singapore); a woman with a
negative test result on screening with Serostrip HIV-1/2 was
considered HIV-seronegative. A positive HIV test with Serostrip
HIV-1/2 was conﬁrmed with Capillus HIV-1/HIV-2 (Cambridge
Diagnostics, Wicklow, Ireland); when both of these rapid tests for
HIV antibodies were positive a woman was considered HIV-
seropositive. In the case of inconclusive rapid tests results (e.g.,
Capillus test indeterminate or a discrepant result compared with
the Serostrip HIV-1/2), a Western blot test was performed to
determine HIV status. HIV-testing of children born to HIV-
seropositive women was conducted using PCR ampliﬁcation of
proviral DNA extracted from peripheral blood mononuclear cells.8
The PCR testing of PCR-negative children was repeated at 12-week
intervals and at the last routine visit of the child. For infants who
tested positive we probed the blood specimens that we had
collected monthly and determined the month of the ﬁrst positive
PCR test result. We retrospectively tagged stool specimens as
coming from HIV-positive or HIV-negative children.
2.3. Deﬁnitions
HIV-positive children (HIV +/+) were children of HIV-seropo-
sitive mothers who had two or more consecutive positive PCR
tests, with the ﬁrst positive test detected within the ﬁrst 4 months
of life. Children of HIV-seropositive mothers were deﬁned HIV-
negative (HIV /+) if they had two or more negative consecutive
PCR tests, and the PCR test of the last visit was negative as well. We
classiﬁed infants for whom we had insufﬁcient PCR data to
determine their status as indeterminate; these infants were
excluded from the analysis. Children of HIV-negative women
were deﬁned as HIV-negative (HIV /). We deﬁned diarrhea as
three or more loose or watery stools per day. We deﬁned an
episode of diarrhea as a new illness if it had been preceded by at
least 7 days without diarrhea; the length of illness was the number
of days during which a child experienced diarrhea during that
episode. Bloody diarrhea was diarrhea with blood visible in the
stool as reported by the mother. A diarrheal episode that lasted 14
days or more was deﬁned as persistent diarrhea.
2.4. Analysis and statistical methods
This was a descriptive study; thus, no formal hypotheses were
tested. Differences in proportions were analyzed using the chi-
square test or Fisher’s exact test when appropriate. Differences in
means were compared by Student’s t-test; differences in medians
were compared using the Kruskal–Wallis test. We calculated
incidence densities as number of diarrheal episodes per 100
person-years of observation, and estimated rate ratios (RR) and
95% conﬁdence intervals (95% CI). We used the statistical programs
SAS (the SAS system for Windows, v. 8.1; SAS, Inc.) and Epicalc
(Epicalc 2000 v. 1.02, http://www.brixtonhealth.com/epicalc.html)
Table 1




Number of pairs with a
follow-up time of the
child of <48 weeks (n = 327)
Number of pairs with a
follow-up time of the child
of 48 weeks (n = 355)
Maternal characteristics
Young age at delivery (<20 years) 206 (30.2) 105 (32.1) 101 (28.5)
Luo ethnicity 582 (85.3) 275 (84.1) 307 (86.5)
Urban residence 528 (77.4) 254 (77.7) 274 (77.2)
Completed primary school 474/680 (69.7) [69.5] 220 (67.3) 254/353 (72.0) [71.5]
Not married at the time of delivery 158 (23.2) 76 (23.2) 82/353 (23.2) [23.1]
Low/medium quality house 523 (76.7) 255 (78.0) 268 (75.5)
Electricity in residence 136/680 (20.0) [19.9] 66 (20.2) 70/353 (19.8) [19.7]
Child characteristics
Firstborn 266 (39.0) 136 (41.6) 130 (36.6)
Low birth weight 38 (5.6) 21 (6.4) 17 (4.8)
Premature 52/680 (7.7) [7.6] 33 (10.1) 19 (5.4)a
Male 348 (51.0) 180 (55.1) 168 (47.3)a
Child/maternal HIV status
HIV-positive child/HIV-positive mother 93 (13.6) 58 (17.7) 35 (9.9)a
HIV-negative child/HIV-positive mother 407 (59.7) 191 (58.4) 216 (60.9)
Child of HIV-negative mother 182 (26.7) 78 (23.9) 104 (29.3)
Death during surveillance 78 (11.4) 62 (19.0) 16 (4.5)a
a Chi-square test: p < 0.05 comparing follow-up time<48 weeks with48 weeks. Missing data: 2missing for level of education, marital status, the presence of electricity,
and prematurity. 1 missing for LBW.
A.M. van Eijk et al. / International Journal of Infectious Diseases 14 (2010) e220–e225e222for all analyses. For all statistical tests, a two-sided p-value of<0.05
was considered signiﬁcant.
2.5. Ethical review
The study protocol was approved by the institutional review
boards at KEMRI (Nairobi, Kenya) and CDC (Atlanta, USA). Issues
concerning case management during the course of the study have
been discussed previously.5 Before enrollment in the study,
informed consent was obtained from the mother for her own
participation (during pregnancy) and for that of her child.
3. Results
3.1. Characteristics of the study population
During the study period, 682 children contributed 610 child-
years of observation (CYO) periods with a median per-child
observation time of 48 weeks (mean 47 weeks). Ninety-three
children (13.6%) were HIV-positive. Over the study period, the
median follow-up timewas less amongHIV+/+children thanamongTable 2
Episodes of diarrhea among children aged <2 years by infant/maternal HIV-status and
Follow-up time (years) Episodes of diarrhea
All 610.2 1209
HIV +/+ 65.5 210
HIV /+ 369.4 672
HIV / 175.2 327
Infants (age 0–364 days)
All 352.9 749
HIV +/+ 42.6 139
HIV /+ 209.1 409
HIV / 101.2 201
Children in their 2nd year of life
All 257.3 460
HIV +/+ 22.9 71
HIV /+ 160.3 263
HIV / 74.0 126
HIV +/+, HIV-positive children; HIV /+, HIV-negative children of HIV-positive mother
a Diarrhea per 100 child-years of observation.theother groups (HIV+/+childrenmedian28weeks (range4–88) vs.
48weeks (range4–96) amongHIV/+ childrenand52weeks (range
4–96)amongHIV/ children;p<0.01bothcomparisons, Kruskal–
Wallis test). Factors associated with a shorter follow-up time (<48
weeks) were child-related and included being male, born prema-
turely, HIV-infected, and dying during the study period (Table 1).
In this study population, breastfeeding was common, but only
exclusively for a short period; water (plain or in combination with
sugar and/or salt), or other foods were introduced at a median age
of 6 weeks (95% CI 5–8 weeks), with no difference by HIV status of
the child/mother pair (data not shown). The median weaning age
was 94 weeks (95% CI 89–97 weeks). Use of antibiotics in the 2
weeks preceding a visit was reported in 62 routine visits (0.8%) and
wasmore common amongHIV +/+ children (2.7%) compared to the
other groups (0.6% and 0.4% among HIV /+ and HIV / children,
respectively; compared to HIV +/+ children, both p <0.01).
3.2. Diarrhea disease characteristics, pathogens, and sensitivity
A total of 1209 episodes of diarrhea were reported (Table 2),
corresponding to 198 episodes per 100 CYO. HIV +/+ childrenage group, Kisumu, 1997–2001
Incidence densitya Rate ratio (95% CI) p-Value
198
321 [318] 1.71 (1.44–2.04) <0.01
182 0.98 (0.85–1.11) 0.36
187 Reference
212
326 [323] 1.64 (1.32–2.03) <0.01
196 0.98 (0.83–1.17) 0.44
199 Reference
179
310 [309] 1.82 (1.36–2.44) <0.01
164 0.96 (0.78–1.19) 0.39
170 Reference
s; HIV /, children of HIV-negative mothers; CI, conﬁdence interval.
Table 3
Features of diarrheal illness and stool culture results in children by HIV-status, Kisumu, 1997–2001
All children, n (%) HIV +/+, n (%) HIV /+, n (%) HIV /, n (%)
Clinical features of diarrhea
Number of episodes 1209 210 672 327
Median duration, days (range) 5 (1–36) 5 (1–36) 5 (1–33) 4 (1–31)
Fever 929 (77.0) [76.8] 172 (82.3)c [81.9] 508 (75.7) [75.6] 249 (76.2)
Vomiting 547 (45.3) [45.2] 98 (46.9) [46.7] 306 (45.6) [45.5] 143 (43.7)
Abdominal cramps 329 (27.3) [27.2] 48 (23.0)d [22.9] 180 (26.8) 101 (30.9)
Poor feeding 645 (53.4) [53.3] 131 (62.7)c,d [62.4] 339 (50.5) [50.4] 175 (53.5)
Bloody diarrhea 61 (5.1) [5.0] 7 (3.3) 31 (4.6) 23 (7.0)
Persistent diarrhea 66 (5.5) 20 (9.5)c 29 (4.3) 17 (5.2)
Stool cultures
Number of active episodesa 948 165 523 260
Stools cultured 630 (66.5) 117 (70.9) 341 (65.2) 172 (66.2)
Stools yielding 1 bacterial pathogen 175 (27.8)b 24 (20.5)d 92 (27.0) 59 (34.3)
Campylobacter 131 (20.8) 17 (14.5)d 69 (20.2) 45 (26.2)
Salmonella 22 (3.5) 5 (4.3) 9 (2.6) 8 (4.7)
Shigella 34 (5.4) 2 (1.7)d 17 (5.0) 15 (8.7)
Control stool samples
Stools cultured 91 7 60 24
Stools yielding 1 bacterial pathogen 20 (22.0) 0 (0.0) 12 (20) 8 (33.3)
Campylobacter 15 (16.5) 0 (0.0) 10 (16.7) 5 (20.8)
Salmonella 1 (1.1) 0 (0.0) 0 (0.0) 1 (4.2)
Shigella 4 (4.4) 0 (0.0) 2 (3.3) 2 (8.3)
HIV +/+, HIV-positive children; HIV /+, HIV-negative children of HIV-positive mothers; HIV /, children of HIV-negative mothers.
aActive episode: episode of diarrhea that was ongoing at the time of visit and had not been reported before at a routine or unscheduled visit.
bTwelve stool cultures yielded more than one pathogen: Campylobacter and Shigella nine times (two HIV /+ and seven HIV / children; bloody diarrhea reported in three
children), and Campylobacter and Salmonella three times (one HIV /+ and two HIV / children, no bloody diarrhea reported).
cp < 0.05 HIV +/+ versus HIV /+ children.
dp < 0.05 HIV +/+ versus HIV / children.
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likely to have episodes of diarrhea compared to HIV / children,
who experienced 187 episodes per 100 CYO (RR 171, 95% CI 1.44–
2.04, p < 0.01, Table 2); however, there was no statistically
signiﬁcant difference observed between HIV /+ and HIV /
children (RR 0.98, 95% CI 0.85–1.11, p = 0.36). The combined rate
for HIV /+ and HIV / children was 183 episodes per 100 CYO.
The median duration of diarrheal illnesses was 5 days (range 1–36
days) and was not statistically different by the child’s HIV status
(Table 3). Fever (77.0%) was the most common symptom
accompanying the diarrheal illness; HIV +/+ childrenwith diarrhea
were more likely to have a history of fever and to feed poorly
compared to HIV /+ and HIV / children (Table 3).
A stool culture was obtained for 630 (66.5%) active diarrheal
episodes (Table 3). Stool cultures were less likely to yield a
bacterial pathogen in HIV +/+ children compared to HIV /
children (p = 0.02), but not compared to HIV /+ children
(p = 0.18). Campylobacter was the most frequent bacterial patho-
gen, isolated from 20.8% of stool cultures, followed by Shigella
(5.4%) and Salmonella (3.5%). No Vibrio was detected. Campylo-
bacter and Shigella were less likely to be isolated from HIV +/+
children compared to HIV / children (Table 3). Twenty-one
percent of the children with Shigella infections experienced bloody
diarrhea, which was signiﬁcantly more frequent than among
children whose stool culture yielded no pathogen (5.5%, p < 0.01).
There was no statistically signiﬁcant difference inmedian duration
of diarrhea by bacterial species detected, but children with mono-
infection with Campylobacter (5/119) were less likely to haveTable 4
Antimicrobial susceptibilities of 56 Shigella and non-typhoidal Salmonella isolates from
Chl Ctx Tet Cpx Na A
Shigella (N = 34) 16 (47.1) 1 (2.9) 2 (5.9) 34 (100) 34 (100) 8
Salmonella (N = 22) 12 (54.6) 7 (31.8) 5 (22.7) 22 (100) 21 (95.5) 6
Data are number and percent (in parentheses) of susceptible isolates.
Chl, chloramphenicol; Ctx, trimethoprim–sulfamethoxazole; Tet, tetracycline; Cpx, cipro
Km, kanamycin; Gm, gentamicin; Ctri, ceftriaxone; Amca, amoxicillin–clavulanic acid.persistent diarrhea than children with mono-infection with
Shigella (4/25, p = 0.05) or Salmonella (3/19, p = 0.08).
The prevalence of any bacterial infection, and of Campylobacter,
Salmonella, and Shigella, detected in 91 stool samples of 67 children
(43% male) without diarrhea at the time of visit or in the week
before or after the visit, was lower than, but not statistically
signiﬁcantly different from, the prevalence among children with
active diarrhea (p = 0.40, 0.34 and 1.00 for Campylobacter,
Salmonella, and Shigella, respectively, Table 3).
Shigella and Salmonella species were largely resistant to available
antibiotics (trimethoprim–sulfamethoxazole, tetracycline, ampicil-
lin, chloramphenicol, and streptomycin), but demonstrated little
resistance to ciproﬂoxacin, nalidixic acid, gentamicin, kanamycin,
and ceftriaxone, antibiotics that were generally not available in this
area (Table 4). Sample sizes were inadequate to meaningfully
compare susceptibility patterns of pathogens by child HIV status.
Among the 202 diarrhea samples from 144 children (62% <1
year of age; 49% male) tested for rotavirus, 28 (13.9%) were
positive. Although rotavirus infection was less common among
HIV +/+ children (2/29 or 6.9%) compared with the other groups
(16/109 or 14.7% among HIV/+ and 10/64 or 15.6% among HIV/
 children), this difference was not signiﬁcant (p = 0.36 and 0.33,
respectively). Rotaviruswas signiﬁcantlymore common in the ﬁrst
half year of infancy (16/64 children (25%) aged 0–25 weeks vs. 12/
138 children (8.7%) aged 26–104 weeks, p < 0.01). No statistically
signiﬁcant difference in median duration of diarrhea was detected
between children with and without rotavirus infection (median 5
days, range 3–14 days vs. median 5 days, range 2–36 days,children with diarrhea in Kisumu, 1997–2001
mp Ssz Stm Km Gm Ctri Amca
(23.5) 1 (2.9) 1 (2.9) 34 (100) 34 (100) 34 (100) 14 (41.2)
(27.3) 6 (27.3) 5 (22.7) 16 (72.7) 15 (68.2) 22 (100) 6 (27.3)
ﬂoxacin; Na, nalidixic acid; Amp, ampicillin; Ssz, sulﬁsoxazole; Stm, streptomycin;
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likely to have persistent diarrhea (14.3% vs. 3.5%, p = 0.03).
A subset of 394 consecutive diarrhea samples provided by 240
children were examined for parasites. No Isospora, Cyclospora,
Blastocystis hominis, Strongyloides, or Schistosoma infections were
detected. Giardia intestinalis was identiﬁed once (HIV / child),
Cryptosporidium spp and hookworm twice (0.5%; Cryptosporidium:
one HIV +/+ and one HIV /+ child; hookworm: two HIV /+
children), Entamoeba histolytica and Trichuris trichiura three times
(0.8%; E. histolytica: one in each child group; T. trichiura: all three
infections in HIV /+ children), and Ascaris lumbricoides was
detected four times (three HIV /+ and one HIV / child).
3.3. Persistent diarrhea
Sixty-six episodes of diarrhea among 62 children lasted 14
days (5.5% of all diarrhea episodes; 10.8 per 100 CYO among all
children): 51 of these episodes (77.3%) occurred in the ﬁrst year of
life (follow-up time as in Table 2). HIV +/+ infants were
signiﬁcantly more likely to experience persistent diarrhea (30.5
per 100 CYO) than children in the other groups (7.8 per 100 CYO for
HIV /+ children and 9.7 per 100 CYO for HIV / children,
p < 0.01). Stool cultures were available for 46 episodes; Campy-
lobacter, Shigella, and Salmonellawere detected in 6 (13%), 5 (11%),
and 3 (7%) episodes, respectively.
3.4. Diarrhea and child death
Seventy-eight children died during follow-up; 36 were HIV +/+
(38.7% of HIV +/+ participants), 32 were HIV /+ (7.9% of HIV /+
participants), and 10 were HIV / (5.5% of HIV / participants).
The majority of deaths occurred in the ﬁrst year of life (58, 74.4%).
Information on the cause of death was available for 74 children
(94.9%).Diarrheawasdiagnosedas the terminal illness for28children
(37.8%), and was not a signiﬁcantly more common cause among HIV
+/+ children who died (14, 41.2%), compared to HIV/+ children (11,
36.7%) or HIV / children who died (3, 30%, overall Fisher’s exact
test p = 0.85). There was no statistically signiﬁcant difference in
the duration of the last diarrheal illness before death by HIV status
(HIV+/+children:median14days, range2–30days;HIV/+children:
median 11 days, range 1–33 days; and HIV/ children: median 10
days, range 3–31 days, Kruskal–Wallis test p = 0.88).
3.5. Discussion
In this study population, diarrhea was more common among
HIV-positive than HIV-negative children in whom it was more
likely to be accompanied by fever and poor feeding. Stool cultures
from HIV-positive children with diarrhea were less likely to yield
routine bacterial pathogens than stool cultures from children of
HIV-negativewomen. Susceptibility testing of the routine bacterial
pathogens we isolated showed high levels of resistance to the
antibiotics commonly used in the community. Diarrhea was
identiﬁed as the direct cause of death for 37.8% of all children
regardless of HIV status.
To explain the increase in diarrhea among HIV-infected
children reported by us and others,2,3,9 some authors have
hypothesized that HIV may induce changes in the intestinal
immune system that increase vulnerability to enteric infections or
that HIV itself may cause diarrhea.10,11 The HIV disease stage-
related release of cytokines may affect enterocyte secretion of
chloride, or may more directly affect the epithelial barrier
function,11 and in this way reduce the threshold that diarrheal
pathogens must overcome to cause illness. HIV-infected children
may also live in environments with greater risk of exposure to
pathogens, ormay usemore antibiotics which can induce diarrhea.Several strategies have been examined to reduce diarrhea
among HIV-infected and uninfected children. Use of water
chlorination and safe water storage can reduce episodes of
diarrhea among HIV-infected children <5 years of age by 30%.12
Among HIV-infected persons of all ages, combining safe water
practices with trimethoprim–sulfamethoxazole prophylaxis
reduced episodes of diarrhea by 67%.12 However, among HIV-
uninfected children <3 years of age, safe water storage and use of
water chlorination was not associated with protection from
diarrhea, suggesting that other routes of exposure (e.g., hand–
mouth contact) may be important in this younger age group. The
effect of trimethoprim–sulfamethoxazole prophylaxis on diarrhea
in HIV-infected children is not clear; a South African study
associated its use with an increased risk of diarrhea in both HIV-
infected and uninfected infants,13 whereas in a Ugandan study its
usewas associatedwith a non-signiﬁcant decrease in the incidence
of diarrhea among HIV-infected children<5 years of age (0.84, 95%
CI 0.41–1.70).9 Vitamin A and zinc supplementation have both
been associated with reduced risks of diarrhea morbidity and
reduced overall child mortality in developing countries;14,15 this
effect seems to extend to HIV-infected children as well,16,17 and
may be a promising additional strategy to reduce diarrhea
morbidity and overall mortality.
There were several limitations to our study. Due to limited local
laboratory capacity at the time the study was conducted, we did
not test routinely for the full complement of viral or parasitic
pathogens, or for diarrheagenic Escherichia coli, which have been
established as important causes of pediatric diarrhea.18,19 Intest-
inal parasitism with geohelminths in the age group studied is
typically low, and generally increases at around 2 years of age.20
Infection with protozoa can be common in this age group, but is
more variable depending on the type and source of drinking water,
especially for Giardia intestinalis and Cryptosporidium spp.21
Because diarrhea surveillance was not instituted at the start of
the larger cohort study, and was interrupted during the study, we
were not able to assess the importance of recurrent diarrhea. The
prevalence of Campylobacter, Salmonella, and Shigella in stool
samples of children without diarrhea was similar compared to
children with diarrhea, raising cautions regarding the interpreta-
tion of a positive stool culture in children with diarrhea; the mere
presence of a bacterial pathogen may not be a sufﬁcient factor to
explain diarrhea.2Wewere unable to obtain complete information
on every child’s diarrhea history; however, we do not feel that any
particular biaswas introduced by themissing data. One should also
interpret cautiously our reported p-values, given the relatively
large number of tests performed and the low number of positive
tests in some comparison groups.
In conclusion, diarrhea was more common among HIV-infected
children, even though bacterial pathogens such as Campylobacter
and Shigella were recovered less frequently from their stool
samples, suggesting that other pathogens (e.g., viruses, parasites,
diarrheagenic E. coli) or other causes (e.g., malabsorption,
metabolic enteritis) may be important in this population.
Improving access to safe water, basic sanitation and hygiene,
and exploring vitamin A and zinc supplementation could help all
children, but may in particular beneﬁt HIV-infected children in
whom diarrheal illness was more frequent, more severe, and more
frequently persistent.
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